News Releases

May 2021

May 11, 2021 5/11/2021 Notice Concerning Issuance of New Shares through Third-Party Allotment associated with Continuation of Stock Grant System for Company Group Management in Japan in Fiscal 2021

May 11, 2021 5/11/2021 Continuation of the Stock Compensation Plan for Directors and the Stock Grant System for Company Group Management in Japan in Fiscal Year 2021

May 11, 2021 5/11/2021 Takeda Proposes Partial Amendment to the Articles of Incorporation

May 11, 2021 5/11/2021 Difference between Forecast and Actual Results for the Fiscal Year Ended March 2021

May 11, 2021 5/11/2021 Takeda Delivers Resilient FY2020 Results with Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected to Accelerate in FY2021

May 6, 2021 5/6/2021 Takeda to Hold Fourth Quarter and Full-Year FY2020 Earnings Conference Calls

April 2021

April 28, 2021 4/28/2021 Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year

April 27, 2021 4/27/2021 Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer

April 2, 2021 4/2/2021 CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune Globulin Medicine